Objective To evaluate the clinical effects of ray protective agent which prevented radiation dermatitis in head carcinoma patients.Methods 112 patients which prevented radiation dermatitis in head carcinoma patients were divided into the two groups by the single-blind random method.The treated group of 60 patients received the spray of ray protective agent on the radiated skin area 30 min prior and after the radiation exposure with health education,and the control group of 52 patients without any treatment for protection,except health education.The radiation-induced skin damage was observed and the incidence of skin damage was assessed.Results The incidence of 2 and 3 degree skin reaction of the treated group were 15 cases(25.0％) and 4 cases(6.7％),and the incidence of 2 and 3 degree skin reaction of the control group were 21 cases(40.4％) and 28 cases(53.8％),the difference between the two groups had statistical significance(x2 =48.902,24.113,all P ＜ 0.05).Conclusion Ray protective agent is an effective way in reducing the degree of radiation dermatitis,which can relieve pain and improve the quality of life.

Objective To improve the understanding of perioperative anesthesia management in patients with anti-N-methyl-D-aspartate receptor encephalitis combined with a history of ovarian teratoma.Methods Case information of 10 patients with anti-N-methyl-D-aspartate receptor encephalitis with a history of ovarian teratoma admitted to the Third Affiliated hospital of Sun yat-sen University from July 2014 to November 2018 were retrospectively analyzed.Results A total of 10 patients received treatment,8 improved after treatment,2 had poor prognosis,and their families required discharge.All patients received endotracheal intubation under general anesthesia.Conclusions Anesthesiologists should pay attention to perioperative anesthesia management of patients with anti-N-methyl-D-aspartate receptor encephalitis complicated with ovarian teratoma,including preoperative evaluation,anesthesia methods and drug selection,intraoperative and postoperative management.

Scavenging reactive oxygen species (ROS) by antioxidants is the important therapy to cerebral ischemia-reperfusion injury (CIRI) in stroke. The antioxidant with novel dual-antioxidant mechanism of directly scavenging ROS and indirectly through antioxidant pathway activation may be a promising CIRI therapeutic strategy. In our study, a series of chalcone analogues were designed and synthesized, and multiple potential chalcone analogues with dual antioxidant mechanisms were screened. Among these compounds, the most active not only conferred cytoprotection of HO-induced oxidative damage in PC12 cells through scavenging free radicals directly and activating NRF2/ARE antioxidant pathway at the same time, but also played an important role against ischemia/reperfusion-related brain injury in animals. More importantly, in comparison with mono-antioxidant mechanism compounds, exhibited higher cytoprotective and neuroprotective potential and Overall, our findings showed compound could emerge as a promising anti-ischemic stroke drug candidate and provided novel dual-antioxidant mechanism strategies and concepts for oxidative stress-related diseases treatment.

[This corrects the article DOI: 10.1016/j.apsb.2019.01.003.].